Skip to main content
. 2022 Sep 6;2(5):622–632. doi: 10.1016/j.jacasi.2022.04.007

Table 2.

Procedural Patient Characteristics

Overall (N = 2,518) Late Bleeding (n = 140) No Late Bleeding (n = 2,378) P Value
Procedural variables
 Procedure time, min 78.2 ± 39.1 83.7 ± 39.9 77.9 ± 39.0 0.09
 Fluoroscopy time, min 20.7 ± 11.2 20.7 ± 9.9 20.7 ± 11.3 0.96
 Contrast media, mL 114.2 ± 58.4 115.0 ± 50.3 114.2 ± 58.9 0.86
 Length of intensive care unit, d 1.0 (1.0-2.0) 1.0 (1.0-2.0) 1.0 (1.0-2.0) 0.41
 Length of hospital stay, d 10.0 (7.0-15.0) 9.5 (10.0-20.0) 10 (8.0-16.0) 0.85
Type of valve
 Balloon expandable valve 2,187 (86.9) 127 (90.7) 2,060 (86.6) 0.20
 Self-expandable valve 331 (13.1) 13 (9.3) 318 (13.4)
Approach route
 Transfemoral 2,155 (85.6) 122 (87.1) 2,033 (85.5) 0.71
 Nontransfemoral 363 (14.4) 18 (12.9) 345 (14.5)
Procedural complications
 30-d mortality 6 (0.2) 0 (0.0) 6 (0.3) >0.99
 New onset AF 93 (3.7) 4 (2.9) 89 (3.7) 0.60
 Acute coronary occlusion 23 (0.9) 2 (1.4) 21 (0.9) 0.37
 Disabling stroke 32 (1.3) 3 (2.1) 29 (1.2) 0.42
 Hemorrhagic stroke 4 (0.2) 0 (0) 4 (0.2) 0.80
 Acute kidney injury 243 (9.7) 10 (7.1) 233 (9.8) 0.38
 Major vascular complications 97 (3.9) 7 (5.0) 90 (3.8) 0.49
 Life-threatening and major bleeding 349 (13.9) 18 (12.9) 331 (13.9) 0.42
 Minor bleeding 224 (8.9) 15 (10.7) 209 (8.8) 0.26
 None-trivial PVL 1,619 (64.3) 83 (59.3) 1,536 (64.6)
 Mild PVL 854 (33.1) 52 (37.1) 802 (33.7) 0.16
 Moderate-severe PVL 45 (1.8) 5 (3.6) 40 (1.7)
 Need for any cardiac surgery 13 (0.5) 2 (1.4) 11 (0.5) 0.16

Values are mean ± SD, median (IQR), or n (%).

AF = atrial fibrillation; PVL = paravalvular aortic regurgitation.